title: Symposium report: the Waters Bioanalysis World Tour: the broadening impact and future of the DMPK laboratory--addressing large-molecule therapeutics.
abstract: An evening symposium was held at the Museu de Historia de Catalunya (Barcelona, Spain) as a precursor to the European Bioanalysis Forum meeting, as part of the Waters Corporation Bioanalysis World Tour. The symposium was chaired by Robert Plumb and Jing Lin (Waters Corporation, MA, USA) with a focus on the future of the DMPK laboratory and its role in addressing large-molecule therapeutics and biomarkers. Lieve Dillen (Johnson and Johnson, Belgium) spoke on ultra-sensitive peptide quantification, Richard Kay (Quotient Bioresearch, UK) discussed quantifying proteins and peptides in plasma, Ian Wilson (AstraZeneca, UK) covered metabolic biomarkers and Robert Plumb concluded the evening with a presentation on the future of MS in DMPK studies. Following the presentations, all the speakers took questions from the audience and continued lively discussion over a cocktails and canapés reception.
authors.affiliation: Future Science Group, London, UK. r.devooght-johnson@future-science.com
authors.forename: Ryan
authors.initials: R
authors.lastname: De Vooght-Johnson
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015415:Biomarkers / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004867:Equipment Design; D006801:Humans; D013058:Mass Spectrometry / Q000295:instrumentation / Q000379:methods / Q000639:trends; D008969:Molecular Sequence Data; D010455:Peptides / Q000032:analysis*; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000378:metabolism; D011506:Proteins / Q000032:analysis*; D013030:Spain; D016482:Urinalysis / Q000379:methods
chemical_list: D015415:Biomarkers; D010455:Peptides; D004364:Pharmaceutical Preparations; D011506:Proteins